Skip to main content
logo
Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0101
+0.0001 (1.00%)
At close: Jul 24, 2026

Nymox Pharmaceutical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
-----0.01
Revenue Growth
------95.69%
Gross Profit
-----0
Operating Income
-4.28-4.28-8.35-6.65-12.5-11.72
Net Income
-4.49-4.49-8.84-6.58-12.54-11.74
Earnings Per Share
-0.05-0.05-0.10-0.07-0.15-0.16
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.070.070.071.40.833.61
Total Debt
3.293.290.750.170.390.43
Net Cash (Debt)
-3.21-3.21-0.681.230.443.19
Net Cash Growth
---180.18%-86.22%-37.45%
Net Cash Per Share
-0.03-0.03-0.010.010.010.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-2.6-2.6-4.06-5.21-9.82-10.04
Capital Expenditures
---0--0.01-0.01
Free Cash Flow
-2.6-2.6-4.06-5.21-9.83-10.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
-----20.00%
Operating Margin
------234400.00%
Pretax Margin
------234760.00%
Profit Margin
------234760.00%
FCF Margin
------201000.00%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
-----38367.59